Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Feb 2026 for TELA Bio, Inc., €7,616.
Filing timeline
BuySaleAntony Koblish
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
Closed purchases
Market purchases
7
Positive at T+90
50%
Median T+90
+19.6%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -48.3%Entry US$2.86 · Close at T+365 US$1.48
- -36.7%Entry US$4.80 · Close at T+365 US$3.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Antony Koblish: trading record in brief
Antony Koblish, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in TELA Bio, Inc. and Orthovita Inc. The record holds 31 filings, for trades running from 6 March 2007 to 24 February 2026.
No open-market sale appears; the market trades are 7 purchases worth €265k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 21 share grants.
A typical purchase (the median) is worth €8,971.
The newest entry dates from 24 February 2026: a share grant of €7,616, in TELA Bio, Inc. The last purchase on record was published on 24 October 2024, which is 731 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Antony Koblish
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
12,494 shares@ US$0.71741.6% of flowCommon StockSEC:0001195881-26-000002:1
11,631 shares@ US$0.7661.6% of flowCommon StockSEC:0001195881-26-000002:2
3,900 shares@ US$0.78520.6% of flowCommon StockSEC:0001195881-26-000002:3
176,000 shares0Common StockSEC:0001195881-26-000002:0
384 shares@ US$1.220.2% of flowCommon StockSEC:0001062993-25-006859:0
11,631 shares@ US$2.726.5% of flowCommon StockSEC:0001062993-25-003497:1
5,772 shares@ US$2.653.1% of flowCommon StockSEC:0001062993-25-003497:2
149,000 shares0Common StockSEC:0001062993-25-003497:0
88,888 shares@ US$2.2568.4% of flowCommon StockSEC:0001062993-24-017928:0
Canonical exit: 22 Jan 2025 (T+90)
385 shares@ US$5.670.7% of flowCommon StockSEC:0001062993-24-007842:0
5,014 shares@ US$7.077.0% of flowCommon StockSEC:0001062993-24-004581:1
5,726 shares@ US$7.078.0% of flowCommon StockSEC:0001062993-24-004581:2
77,500 shares0Common StockSEC:0001062993-24-004581:0
11,000 shares@ US$4.543317.3% of flowCommon StockSEC:0001062993-23-020847:0
Canonical exit: 12 Feb 2024 (T+90)
385 shares@ US$10.641.4% of flowCommon StockSEC:0001062993-23-008668:0
6,034 shares@ US$11.0313.5% of flowCommon StockSEC:0001062993-23-005025:1
61,200 shares0Common StockSEC:0001062993-23-005025:0
384 shares@ US$11.631.5% of flowCommon StockSEC:0001062993-22-009221:0
2,687 shares@ US$11.9810.5% of flowCommon StockSEC:0001062993-22-005907:0
46,500 shares0Common StockSEC:0001062993-22-005780:0
5,439 shares0Common StockSEC:0001192482-21-000300:0
34,900 shares0Common StockSEC:0001192482-21-000192:0
7,277 sharesCommon StockSEC:0001192482-19-000434:0
14,225 sharesCommon StockSEC:0001192482-19-000434:1
166,738 shares@ US$3.85COMMON STOCKSEC:0001181431-11-038426:0
25 of 31 declarations
